Search research articles
Contact Us
Filters
Showing results (61-70 of 186) with videos related to
Page
of 19
Sort By:
Ugeskrift for Laeger
|
January 23, 1995
[Serum myoglobin as a non-invasive marker of coronary reperfusion after intravenous thrombolytic therapy in patients with acute myocardial infarction]
B Jurlander, P M Clemmensen, E M Ohman, et al.
The Journal of Invasive Cardiology
|
December 9, 1994
Use of the perfusion balloon as a primary dilation device
H R Phillips, E M Ohman, M Labinaz, et al.
European Heart Journal
|
March 1, 1996
Serum myoglobin for the early non-invasive detection of coronary reperfusion in patients with acute myocardial infarction
B Jurlander, P Clemmensen, E M Ohman, et al.
The American Journal of Cardiology
|
December 15, 1994
A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction
C B Granger, H D White, E R Bates, et al.
British Heart Journal
|
June 1, 1990
Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation
E M Ohman, C Casey, J R Bengtson, et al.
Computational Biology and Chemistry
|
June 27, 2006
MicroRNA sequence motifs reveal asymmetry between the stem arms
J Gorodkin, J H Havgaard, M Ensterö, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 18, 1999
Cardiac markers: point of care testing
M P Hudson, R H Christenson, L K Newby, et al.
Journal of the American College of Cardiology
|
June 1, 1997
Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock
P J Kovack, M A Rasak, E R Bates, et al.
American Heart Journal
|
October 20, 1998
Relation between inhibition of platelet aggregation and clinical outcomes
R A Harrington, N S Kleiman, C B Granger, et al.
Chest
|
November 20, 1998
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
J Hirsh, T E Warkentin, R Raschke, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 186) with videos related to
Sort By:
Page
of 19
Ugeskrift for Laeger
|
January 23, 1995
[Serum myoglobin as a non-invasive marker of coronary reperfusion after intravenous thrombolytic therapy in patients with acute myocardial infarction]
B Jurlander, P M Clemmensen, E M Ohman, et al.
The Journal of Invasive Cardiology
|
December 9, 1994
Use of the perfusion balloon as a primary dilation device
H R Phillips, E M Ohman, M Labinaz, et al.
European Heart Journal
|
March 1, 1996
Serum myoglobin for the early non-invasive detection of coronary reperfusion in patients with acute myocardial infarction
B Jurlander, P Clemmensen, E M Ohman, et al.
The American Journal of Cardiology
|
December 15, 1994
A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction
C B Granger, H D White, E R Bates, et al.
British Heart Journal
|
June 1, 1990
Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation
E M Ohman, C Casey, J R Bengtson, et al.
Computational Biology and Chemistry
|
June 27, 2006
MicroRNA sequence motifs reveal asymmetry between the stem arms
J Gorodkin, J H Havgaard, M Ensterö, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 18, 1999
Cardiac markers: point of care testing
M P Hudson, R H Christenson, L K Newby, et al.
Journal of the American College of Cardiology
|
June 1, 1997
Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock
P J Kovack, M A Rasak, E R Bates, et al.
American Heart Journal
|
October 20, 1998
Relation between inhibition of platelet aggregation and clinical outcomes
R A Harrington, N S Kleiman, C B Granger, et al.
Chest
|
November 20, 1998
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
J Hirsh, T E Warkentin, R Raschke, et al.
Page
of 19